To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Laryngitis
Laryngitis is an inflammation of the larynx. It causes hoarse voice or the complete loss of the voice because of irritation to the vocal folds (vocal cords) Laryngitis is categorized as acute if it lasts less than a few days.[1] Otherwise it is categorized as chronic, and may last over 3 weeks.
Additional recommended knowledge
Causes
Symptoms
Symptoms of laryngitis include a weak and raspy voice, and a dry and sore throat (accompanied with dry coughing), tickling in throat. The patient might also complain of pain when swallowing or feeling as if the larynx is swollen. These may also be accompanied by cold-like symptoms (blocked nose etc.) TreatmentsCorrect treatment depends on a correct diagnosis of the underlying cause of laryngitis. The most prevalent cause of a missed diagnosis of laryngeal cancer is a belief that persistent hoarseness is due to laryngitis.[citation needed] Should hoarseness last for more than 3 weeks, one should consult an otorhinolaryngologist (ear, nose, and throat physician) for an examination including direct visualization of the vocal cords. This examination may also detect the presence of vocal cord nodules, a structural change resulting in persistent hoarseness or loss of voice. If laryngitis is due to a viral cause:
If laryngitis is due to gastroesophageal reflux:
If laryngitis is due to a bacterial or fungal infection:
If persistent hoarseness or loss of voice (sometimes called "laryngitis") is a result of vocal cord nodules:
References
|
|||||||||||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Laryngitis". A list of authors is available in Wikipedia. |
- Dithranol
- Flexor_hallucis_longus_muscle
- DeCODE and Illumina Form Alliance to Develop and Commercialize DNA-based Diagnostics - Companies to initiate work on molecular diagnostics for the risk of heart attack, type 2 diabetes and breast cancer
- HIV
- Reduction of electrostatic charge to ensure proper volume transfer and trajectory - Quality improvement in high throughput applications